BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.23 EUR | -0.27% |
|
+1.79% | -42.81% |
| Dec. 03 | BAYER AG : JP Morgan reaffirms its Neutral rating | ZD |
| Dec. 03 | ZBD Pharma Gets China Approval for Antibacterial Injection | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 19.88B | - | |||||
| 720B | ||||||
| 483B | ||||||
| 373B | ||||||
| 321B | ||||||
| 255B |
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Sector Chart